SCHEMBL34464

SCHEMBL34464

O=C(O)CCN1C(=O)C=CC1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 7/20 0.70
PTGS2 P35354 7/20 0.70
MGLL Q99685 6/20 0.54
FAAH O00519 3/20 0.54
ALDH1A1 P00352 2/20 0.54
PKM P14618 2/20 0.54
MAPK1 P28482 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
LMNA P02545 2/20 0.52
HSP90AA1 P07900 1/20 0.52
TLR9 Q9NR96 1/20 0.52
TP53 P04637 1/20 0.52
MAPT P10636 1/20 0.52
HPGD P15428 1/20 0.52
XBP1 P17861 1/20 0.52
HTT P42858 1/20 0.52
RECQL P46063 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
GPR35 Q9HC97 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15391717 1.00 PTGS1 (0.70) PTGS1PTGS2MGLLFAAHALDH1A1
Hydrochloric Acid SCHEMBL25414956 0.98 PTGS1 (0.68) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL28981238 0.98 PTGS1 (0.68) PTGS1PTGS2MGLLFAAHALDH1A1
Hydrazine SCHEMBL20561226 0.96 PTGS1 (0.66) PTGS1PTGS2MGLLFAAHALDH1A1
Alcohol SCHEMBL29133202 0.92 PTGS1 (0.61) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL155346 0.86 PTGS1 (0.85) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL14655126 0.86 PTGS1 (0.55) PTGS1PTGS2MGLLFAAHALDH1A1
Succinimide SCHEMBL28182577 0.85 PTGS1 (0.54) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL1069132 0.85 PTGS1 (0.54) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL3047985 0.85 PTGS1 (0.81) PTGS1PTGS2MGLLFAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5032 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080388-A Malaylmethylamine polyethylene glycol activated grease and preparation method thereof 2026-05-26 CN claimed
CN-122006676-A Nanoparticle for enriching low-abundance protein in blood plasma, preparation method thereof and application thereof in early cancer screening 中国科学院长春应用化学研究所 2026-05-12 CN claimed
EP-4676543-A1 METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND HER2 KINASE INHIBITORS Seagen Inc. (US) 2026-01-14 EP claimed
US-12491410-B2 Multi-layer golf ball with thermo-reversible covalent adaptable network ACUSHNET COMPANY (US) 2025-12-09 US claimed
WO-2025243208-A2 PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF HOVIONE - FARMACIÊNCIA, SA (PT) 2025-11-27 WO claimed
US-20250296960-A1 PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF D&D PHARMATECH INC. (KR) 2025-09-25 US claimed
WO-2025122010-A1 A METHOD FOR PURIFYING A MODIFIED GELATIN SENTRYX B.V. (NL) 2025-06-12 WO claimed
CN-120119253-A High-stability titanium etching solution and preparation method and application thereof 浙江奥首材料科技有限公司 2025-06-10 CN claimed
CN-120058851-A Ciprofloxacin nano prodrug, preparation method and application thereof 天津工业大学 2025-05-30 CN claimed
US-20250163101-A1 METHOD FOR INCREASING PRODUCTION YIELD OF ANTIBODY-DRUG CONJUGATE BY USING THIOL-REACTIVE ADDITIVE Research & Business Foundation Sungkyunkwan University (KR) 2025-05-22 US claimed
EP-1042003-A1 DELIVERY OF LONG LASTING THERAPEUTIC AGENTS BY FORMING COVALENT ATTACHMENTS IN VIVO Conjuchem, Inc. (CA) 2000-10-11 EP claimed
US-6107489-A CHEMICALLY REACTIVE TRIPEPTIDE INTERMEDIATES WHICH CAN REACT WITH AVAILABLE REACTIVE FUNCTIONALITIES ON BLOOD COMPONENTS TO FORM COVALENT LINKAGES, THE RESULTING CONJUGATES HAVE RENIN INHIBITION ACTIVITY FOR EXTENDED PERIODS OF TIME CONJUCHEM, INC. (CA) 2000-08-22 US claimed
EP-1007561-A2 NOVEL CONJUGATES OF OPIOIDS AND ENDOGENOUS CARRIERS Conjuchem, Inc. (CA) 2000-06-14 EP claimed
WO-1999044100-B1 CURABLE COMPOSITIONS COATES BROTHERS PLC (GB) 1999-10-21 WO claimed
WO-1999048536-A2 DELIVERY OF LONG LASTING THERAPEUTIC AGENTS BY FORMING COVALENT ATTACHMENTS IN VIVO CONJUCHEM, INC. (CA) 1999-09-30 WO claimed
EP-0942932-A1 MULTIMERIC ERYTHROPOIETIN WITH INCREASED BIOLOGICAL ACTIVITY Beth Israel Deaconess Medical Center (US) 1999-09-22 EP claimed
WO-1999044100-A1 CURABLE COMPOSITIONS COATES BROTHERS PLC (GB) 1999-09-02 WO claimed
WO-1999038891-A1 MULTIMERIC ERYTHROPOIETIN WITH ALTERED BIOLOGICAL ACTIVITY BETH ISRAEL DEACONESS MEDICAL CENTER (US) 1999-08-05 WO claimed
WO-1999024074-A2 NOVEL CONJUGATES OF OPIOIDS AND ENDOGENOUS CARRIERS CONJUCHEM, INC. (CA) 1999-05-20 WO claimed
WO-1998023643-A1 MULTIMERIC ERYTHROPOIETIN WITH INCREASED BIOLOGICAL ACTIVITY BETH ISRAEL DEACONESS MEDICAL CENTER (US) 1998-06-04 WO claimed